Change of ownership in Nerliens Meszansky AS
Publisert 01. desember 2017
A new and exiting era for the company starts now!.
Nerliens Meszansky AS’ roots trace back to 1917 and the company has during these 100 years been familiy owned. The Meszansky and Gihbsson families have been main shareholders since 2003. Now, a new era for the company starts.
On December 1st 2017, the Norwegian holding company Vind AS purchased 98 % of the shares in Nerliens Meszansky AS. CEO Asbjørn Jacobsen retains his minority shareholding in Nerliens Meszansky AS.
Vind has a long term perspective on their ownership. Vind’s ambition is to develop and strengthen Nerliens Meszansky AS’ position as a supplier to the health-, research- and industrial sectors through growth, increased competitive strength, innovation and through capitalizing on already established synergies in the Nordic market.
The company name Nerliens Meszansky AS is well established and will be continued. The company will still supply instruments, reagents, laboratory consumables and technical/application services to existing and new market segments. The Swedish subsidiary Nordic Biolabs AB, which operates across the Nordic countries, will also keep its company name and will constitute an important part of the group strategy going forward.
In its markets, Nerliens Meszansky AS represents a number of renowned and well established suppliers. Several of these suppliers are also represented by Nordic Biolabs AB.
Questions related to the change in ownership can be addressed to CEO of Nerliens Meszansky AS, Asbjørn Jacobsen, or to Harald Høegh at Vind AS.
Oslo, December 1st, 2017